Related Experiment Video

Updated: Jul 7, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

[Mild cognitive impairment with predictors of rapid decline]

H Förstl1, H Bickel, L Frölich

  • 1Klinik & Poliklinik für Psychiatrie & Psychotherapie, TU München, Klinikum rechts der Isar, Ismaningerstr. 22, 81675 München. hans.foerstl@lrz.tu-muenchen.de

Deutsche Medizinische Wochenschrift (1946)
|February 22, 2008
PubMed

Insights

Mild cognitive impairment (MCI) often progresses to dementia. Identifying rapid decline predictors like age and cognitive deficits in MCI patients is crucial for early intervention.

Area of Science:

  • Neurology
  • Geriatrics
  • Psychiatry

Context:

  • Mild cognitive impairment (MCI) affects a significant portion of the elderly population.
  • Approximately 50% of individuals with MCI transition to dementia within four years.
  • Understanding MCI progression is vital for developing timely interventions.

Purpose:

  • To identify key predictors of rapid cognitive decline (MCI-plus) in patients diagnosed with MCI.
  • To analyze scientific literature for factors associated with faster deterioration in MCI patients.

Summary:

  • Key predictors of rapid cognitive decline in MCI include advanced age, prior rapid decline, severity/multiplicity of cognitive deficits, somatic comorbidities, and specific biomarkers.
  • Cerebrospinal fluid findings indicative of Alzheimer's disease and apolipoprotein E4 polymorphism are significant indicators.
  • Associated psychological factors include anxiety, depression, apathy, and subtle daily living difficulties.

Impact:

  • MCI-plus identification enables targeted medical and psychological prophylaxis strategies.
  • Early intervention can potentially slow or mitigate the progression from MCI to dementia.
  • This research highlights the importance of a multi-faceted approach to managing MCI patients.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...